StocksMedium•29 September 2026•
1 min read
Cosmos Health Subsidiary CosmoFarm Hits $60M Annualized Revenue Run-Rate
Key Facts
1Cosmos Health's subsidiary CosmoFarm achieved record Q2 2026 revenue exceeding $15 million, an annualized run-rate of over $60 million.
2CosmoFarm revenue grew 4.3x under Cosmos Health ownership, with daily served pharmacies increasing to approximately 360.
3The company aims for CosmoFarm annualized revenue above $100 million, supported by robotics and AI-enabled infrastructure capacity.
Cosmos Health's subsidiary CosmoFarm achieved record Q2 2026 revenue exceeding $15 million, representing an annualized run-rate of over $60 million. ACCESS Newswire reported that CosmoFarm revenue has grown 4.3x under Cosmos Health ownership, as the number of daily served pharmacies increased to approximately 360.
The company aims to reach annualized revenue above $100 million for CosmoFarm, supported by robotics and AI-enabled infrastructure capacity. In equity markets, COSM closed at $0.3702 on September 28, 2026, having traded between a day low of $0.355 and a high of $0.3995 during that session.